NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
Fund Type	Equity	Equity
Risk	Very High	Very High
Min SIP Amount	₹500	₹100
Min Lumpsum	₹5,000	₹100
Expense Ratio	0.89%	1.03%
NAV	₹20.64 (11 Nov 2026)	₹18.64 (11 Nov 2026)
Fund Size	₹266.72 Cr	₹860.74 Cr
Fund Started	08 Nov 2021	11 Dec 2023
Lock-in Period	No lock-in	No lock-in
Exit Load	If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL.	0.5%For redemption / switch out within 30 days from the date of allotment NilIf units are redeemed or switched out on or after 30 days from the date of allotment

Returns	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
1M	8.44%	7.84%
3M	3.35%	7.51%
6M	13.49%	21.73%
1Y	17.13%	33.07%
3Y	20.85%	—
5Y	15.59%	—
Since Inception	15.59%	23.83%

Trailing risk-adjusted performance measures

Risk Ratio	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
Alpha	-0.46	3.24
Beta	0.96	0.97
Sharpe	0.86	0.88
Standard Deviation	4.76	4.69

Holding Analysis	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
Top 5 Holdings	36.48%	37.56%
Top 10 Holdings	56.97%	54.93%
Portfolio Turnover	0.47	27.27
Equity	99.31%	98.96%
Debt	—	1.21%
Cash	—	—

Name	Assets
Sun Pharmaceutical ...Equity	11.96%
Divis Laboratories LtdEquity	9.51%
Apollo Hospitals En...Equity	5.45%
Torrent Pharmaceuti...Equity	4.78%
Dr Reddys Laborator...Equity	4.78%
Max Healthcare Inst...Equity	4.49%
Cipla LtdEquity	4.19%
Laurus Labs LtdEquity	4.02%
Aurobindo Pharma LtdEquity	4.01%
Mankind Pharma LtdEquity	3.78%

Name	Assets

Fund Manager	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
Name	,

About	ITI Pharma and Healthcare Fund - Dir (G)	Kotak Healthcare Fund - Direct (G)
AMC	ITI Mutual Fund	Kotak Mahindra Mutual Fund
Scheme Category	Sectoral Fund	Sectoral Fund
Benchmark	NIFTY Healthcare TRI	NIFTY Healthcare TRI
Launch Date	18 Oct 2021	20 Nov 2023

Sun Pharmaceutical ...Equity	13.42%
Divis Laboratories LtdEquity	10.23%
Acutaas Chemicals LtdEquity	4.88%
Molbio Diagnostics LtdEquity	4.74%
Torrent Pharmaceuti...Equity	4.29%
Laurus Labs LtdEquity	4.19%
Max Healthcare Inst...Equity	3.50%
Gland Pharma LtdEquity	3.24%
Apollo Hospitals En...Equity	3.24%
Cipla LtdEquity	3.20%